. It is well known that these MSC play an important role in the regeneration of periodontal ligament and alveolar bone. The heterodimeric bone morphogenetic protein (BMP-2/-7) is a very potent BMP. However, BMP and TGF-1 signaling pathways that induce and regulate osteogenesis of HPDL cells are not well understood. It was reported that phosphatidylinositol 3-kinase (PI3K), which is activated by insulin-like growth factor-1 (IGF-1) and subsequently promotes the Akt phosphorylation, might play an important role in BMP-2/-7 and TGF-1-induced osteogenesis. There are numerous signaling pathways located downstream of PI3K/Akt, including the mTOR/p70S6K pathways that was the focus of this study. Here we show that TGF-1 is a more potent inducer of osteogenesis of HPDL cells than BMP-2/-7. LY294002, a PI3K inhibitor, and rapamycin, an inhibitor of mammalian target of rapamycin (mTOR), decreased both the Smad 3 phosphorylation and the osteogenic differentiation induced by TGF-1 treatment. In contrast, the phosphorylation of Smad1/5/ 8 by BMP-2/-7 treatment was affected by neither LY294002 nor rapamycin treatment and mTOR inhibition failed to reduce BMP-2/-7-induced osteogenesis of HPDL cells. Thus the PI3K -mTOR pathway is required for TGF-1-induced osteogenesis but is not essential for osteogenesis induced by BMP-2/-7. In conclusion, the PI3K/mTOR/p70S6K pathway plays different roles in the regulation of osteogenic differentiation by TGF-1 and BMP-2/-7.
Introduction
Teeth are supported by periodontal ligament (PDL) through which forces applied to the teeth can be transmitted to the supporting alveolar bone. PDL is composed of several different kinds of cells and is enriched in mesenchymal stem cells. It is well established that mechanical stresses lead to a variety of PDL cellular responses including deposition or resorption of bone, depending upon whether the tissues are exposed to a tensile or compressive mechanical strain 1) . Although new bone that is added to alveolar bone at the side of the tooth that is exposed to tension is usually presumed to have originated from the alveolus, several mesenchymal cells in the PDL do exhibit osteogenic potential and can produce the osteoblast-related matrix proteins osteopontin, alkaline phosphatase (ALP), and bone sialoprotein 2) . Therefore, it seems likely that, under certain conditions, PDL cells have the capacity to differentiate into osteoblasts. PDL cells with osteogenic potential might have distinct mechanisms for induction of osteogenic differentiation. Normal human periodontal ligament (HPDL) cells are a heterogeneous population of cells, among which precursor cells of various cell lineages exist. Nagata et al. reported that the potency of HPDL cells for establishment of osteoblastic lineage cells, and the changes in expression of key osteogenic differentiation molecules such as insulin-like growth factor-1/2, alkaline phosphatase, type I collagen, and osteocalcin in such cells were similar to those of bone marrow cells or immature osteoblast-like cells undergoing osteogenic differentiation 3) . The combined results suggest that osteogenic In the present study, mesenchymal PDL cells (mostly fibroblastic cells) were treated with bone morphogenetic proteins (BMPs) or TGF-1, which induce the expression of multiple genes that are involved in osteogenesis. BMPs are TGF-family proteins, and it is known that BMP-2 and BMP-7 can strongly induce osteogenesis of bone marrow mesenchymal stem cells [4] [5] [6] . BMP-2/-7 heterodimers are usually the most potent osteogenic inducers 7) . On the other hand, TGF-1 exhibits complex osteogenic effects depending upon such factors as the cell origin, the stage of differentiation, and cell number 8, 9) . Ochiai et al. previously showed that low dose TGF-1 induced osteogenesis in HPDL cells 10) . 
Alkaline phosphatase (ALP) staining
Three days after stimulation, cells were washed two times with phosphate-buffered saline (PBS), fixed with 4% paraformaldehyde for 5 min at room temperature, and washed three times with water. For staining, an ALP substrate solution (Roche Diagnostics, Basel, Switzerland) was added to the fixed cells for 60 min at room temperature. After staining, cells were washed three times with distilled water and images were scored.
Quantitative real-time PCR (qRT-PCR)
Total RNA was extracted from cultured cells using the QIAzol reagent (Qiagen Inc., Valencia, CA, USA) according to the manufacturer's instructions. cDNA was synthesized using a highcapacity cDNA reverse transcription kit (Applied Biosystems, Foster City, CA, USA). qRT-PCR analysis was performed using the Premix Ex Taq TM reagent (Takara Bio Inc., Shiga, Japan) according to the manufacturer's instructions. The target genes were RUNX2, alkaline phosphatase (ALP), type1collagen (COL1A1), osterix (OSX) and osteocalcin (OCN). 18S rRNA was used as an internal control. All primers and probes of these target genes are described in table 1 and were designed using Probefinder v2.45 (http://qpcr.probefinder.com/roche3.html).
Protein extraction and immunoblotting
The cells were lysed with lysis buffer (10 mM Tris-HCl pH 7.5, 150 mM NaCl, complete protease inhibitor mixture, 1 mM sodium orthovanadate, and 1% NP-40), and the protein content was measured using a DC Protein Assay Kit (Bio-Rad, Marnes- 
Statistical analysis
When ANOVA indicated differences among the groups, multiple comparisons between each experimental group were performed using the Bonferroni test. Statistical significance was defined as p < 0.05.
Result
The effect of TGF-1 and BMP-2/-7 on osteogenesis BMP-2/-7 treatment promoted ALP activity, a marker of osteogenesis, in HPDL cells, as assessed using histochemical and qRT-PCR assays (Fig. 1A, C) . However BMP-2/-7 induced significantly less ALP activity than TGF-1. Analysis of the mRNA expression of other osteogenic differentiation genes by qRT-PCR indicated that RUNX2 expression was significantly induced by both TGF-1 and BMP-2/-7 treatment (Fig. 1B) . However, the expression of ALP and COL1A1 was significantly higher than control following TGF-1 treatment but not following BMP-2/-7 treatment (Fig. 1C, D ).
LY294002 and rapamycin inhibited the phosphorylation of

Smad3 induced by TGF-1
We next analyzed potential signaling pathways that might mediate the effects of TGF-1 and BMP-2/-7 on osteogenesis. As shown in Fig. 2 , Akt phosphorylation was significantly upregulated by TGF-1 stimulation, as assessed by western blotting using an anti-phosphorylated Akt antibody. This Akt phosphorylation was completely inhibited by LY294002, which is an effective inhibitor of Akt. BMP -2/-7 treatment slightly upregulated Akt phosphorylation, and this upregulation was completely blocked by LY294002. Treatment with the mTOR inhibitor rapamycin had no effect on Akt phosphorylation. The phosphorylation of p70S6K (an Akt target molecule) was also elevated upon TGF-1 stimulation. This phosphorylation was much stronger when the cells were stimulated with BMP-2/-7. Rapamycin treatment diminished the p70S6K phosphorylation that was induced either by TGF-1 or BMP-2/-7 ( Fig. 2) .
TGF-1-activated Smad3 phosphorylation was significantly inhibited by LY294002 and rapamycin treatment (Fig. 3A, B) . In contrast, the phosphorylation of Smad1/5/8 by BMP-2/-7 treatment was affected by neither LY294002 nor rapamycin treatment (Fig.   3C ). The effect of LY294002 and rapamycin on TGF-1 and BMP-2/-7 induction of ALP expression was measured using histochemical staining. LY294002 completely abolished, and rapamycin inhibited, ALP activity induced by TGF-1 (Fig. 3D) .
In contrast, BMP-2/-7-induced ALP activity was unaffected by rapamycin treatment, but was markedly inhibited by LY294002 (Fig. 3D) .
Rapamycin down-regulated osteogenesis induced by TGF-1
We next investigated whether inhibition of PI3K/Akt or mTOR/ p70S6K pathways affected the mRNA expression of osteogenic differentiation marker genes. LY294002 treatment markedly decreased the mRNA expression of all osteogenic differentiation marker genes that were induced by treatment with TGF-1 or BMP-2/-7. TGF-1-induced RUNX2 mRNA expression, but not that induced by BMP-2/-7, was also significantly decreased by treatment with rapamycin (Fig. 4A) . Similar results were observed when the expression of ALP and COL1A1 was assayed (Figs. 4B, C). OSX mRNA expression was not detected in cells treated with TGF-1 but BMP-2/-7 treatment markedly increased OSX mRNA expression (Fig. 4D ). This increase was inhibited by LY294002
J.Hard Tissue Biology Vol. 21 (4) :359-366, 2012 treatment, whereas rapamycin treatment did not induce any change in BMP-2/-7-induced OSX expression. BMP-2/-7 induced a higher level of OCN mRNA expression than TGF-1. However, OCN expression induced by both agents was decreased by both LY 294002 and rapamycin. Inhibition by rapamycin was stronger than that by LY294002 for TGF-1 induced OCN expression (Fig. 4E) .
Discussion
Many previous reports demonstrated that MAPK and PI3K/ Akt regulate signal transduction by the TGF-family 11) . However, there has been little information regarding the signaling mechanisms that underlie osteogenic differentiation in HPDL cells.
In this study, the differential regulation of osteogenic differentiation of HPDL cells by TGF-1 and BMP-2/-7 was investigated.
The HPDL cells used in this study have only been defined as pan cytokeratin negative cells. Thus they must be composed of a heterogeneous population of mesenchymal cells, osteoprogenitors, and fibroblasts 3) . Indeed, HPDL cells express RUNX2 at slightly higher levels than normal human dermal fibroblasts (data not shown), but ALP mRNA expression and activity can barely be detected. However, following TGF-1 and BMP-2/-7 treatment, osteogenic differentiation was promoted and was accompanied by the induced expression of RUNX2 and ALP (Fig. 1A,B) as well as of various other osteogenic differentiation markers. In this study, we analyzed potential signaling mechanisms through which TGF-1 and BMP-2/-7 induced these effects. Since insulin-like growth factor-1 is known to be an essential factor for osteogenesis of bone marrow mesenchymal stem cells, we focused our study on the potential role of PI3K in the regulation of these effects. It is clear from various studies that BMP promotes ectopic osteogenesis and bone regeneration 12) , and BMP is applied in clinical settings for this purpose. It is also known that BMP plays a significant role in osteogenesis and has a strong impact on osteogenic differentiation 13, 14) . However, TGF-has complex effects on cell function, and can be both an inducer and an inhibitor of osteogenic differentiation [15] [16] [17] [18] , which is known as the dual effect of TG F-. Ochiai et al. reported that low dose TGF-1 treatment promoted osteogenic differentiation whereas high dose TGF-1 treatment of HPDL cells had much weaker effects on osteogenic differentiation 10) . They showed that repetitive treatment with low doses o f TGF-1 stro ngly do wn-regu lated o steogenic differentiation. Thus, TGF-1 can both positively and negatively regulate osteogenic differentiation depending upon the duration of TGF-1 treatment or the differentiation stage of the cells 8, 18, 19) .
Several other reports have also described a key role for TGF-1 in osteoblast precursor cells during bone repair and in acceleration of bone formation 20, 21) . In this study, BMP-2/-7 increased ALP activity and promoted osteogenic differentiation of HPDL cells (Fig. 4B) . However, BMP-2/-7 induction of ALP activity was lower 364 than that induced by TGF-1 (Fig. 4B) . Similarly, TGF-1 more strongly induced the expression of RUNX2, ALP, and COL1A1 than BMP-2/-7 ( Fig. 4A-C) . Thus, in contrast to the results of a previous study of bone marrow mesenchymal stem cells 22) , these data suggested that osteogenic differentiation of HPDL cells is promoted by TGF-1 more strongly than by BMP-2/-7.
In a previous study by Ochiai et al. , the ALK5 inhibitor SB505124 dose-dependently decreased TGF-1-induced ALP in parallel with a decrease in phosphorylated Smad3 10) . Thus, phosphorylation of Smad3 plays a significant role in osteogenic differentiation of HPDL cells by TGF-β1. We therefore examined th e re la ti on sh ip be twee n P I 3K /Akt ac ti vi ty a nd t he phosphorylation of Smads in the present study. In this study, the PI3K/Akt inhibitor LY294002, as well as rapamycin, an inhibitor of mammalian target of rapamycin, decreased TGF-β1-induced phosphorylation of Smad3 in parallel with a decrease in the level of the osteogenic differentiation marker ALP (Fig. 3A, B, D) . However, these inhibitors did not change Smad1/5/8 phosphorylation induced by BMP-2/-7 stimulation (Fig. 3C) . These data are consistent with several previous studies that have indicated that the Smad pathway is a key TGF-β1 signaling pathway and modulates osteogenesis 16) .
It has been reported that regulation of PI3K signaling and activity is important for osteogenic differentiation 23) . Several reports have shown that PI3K inhibition by LY294002 completely abolishes ALP activity and osteogenic differentiation (24) .
Moreover, the p70S6K pathway that is downstream of PI3K/Akt and which is inhibited by rapamycin has an important role in BMP family induction of osteogenic differentiation of rat MSC 4, 25) .
However, the osteogenic effects of rapamycin have been controversial 26) . Tang et al. reported that rapamycin reduced ALP activity in a mouse osteoblastic cell line and a mouse bone marrow stromal cell line 27) . Shoba and Lee reported that rapamycin reduced ALP activity that was promoted by osteogenic protein-1 and insulin-like growth factor-1 in rat fetal calvaria cells 25) . Ogawa et al. reported that rapamycin could promote the differentiation of an immature rat osteoblast-like osteosarcoma cell line 28) . Hofbauer et al. reported that rapamycin decreased the expression of osteoprotegerin mRNA in a human marrow stromal cell line;
however it increased the expression of osteoprotegerin mRNA in a human osteoblastic cell line 29) . Thus, rapamycin does affect osteoblasts differentiation; however, the exact mechanisms by which it modulates osteogenic differentiation are still unclear and quite complicated. TGF-β1 and BMP-2/-7 both promote osteogenic differentiation. However, our data suggest that they so by different signaling pathways, which involve PI3K/Akt/mTOR. Thus, TGF-β1 strongly promotes the expression of early osteogenic differentiation markers and activation of the PI3K/Akt/p70S6K pathway, which is required for these effects, but BMP-2/-7 only mildly affects osteogenic differentiation and does not require 
